CRP100 - Clinical Trial Regulations
Semester | |
School | |
Last revision date | 2024-09-07 16:26:53.293 |
Last review date | 2024-09-07 16:26:53.293 |
Subject Title
Clinical Trial Regulations
Subject Description
This course provides an overview of the regulatory framework for the conduct of clinical trials. Topics include the role of regulatory agencies in the approval of new drugs/devices, relevant clinical trial regulations, the clinical trial application process and an evaluation of global healthcare systems as a factor in the conduct of clinical trials.
Credit Status
One credit toward the Clinical Research Certificate Program
Learning Outcomes
Upon successful completion of this subject the student will be able to:
1. Examine the organization of regulatory agencies and their role in the approval of new medications, medical devices
2. Demonstrate a general understanding of regulations and guidelines required to conduct clinical trials
3. Describe the clinical trials application process
4. Demonstrate an understanding of requirements for clinical trials by different regulatory agencies in different jurisdictions.
Academic Integrity
Seneca upholds a learning community that values academic integrity, honesty, fairness, trust, respect, responsibility and courage. These values enhance Seneca's commitment to deliver high-quality education and teaching excellence, while supporting a positive learning environment. Ensure that you are aware of Seneca's Academic Integrity Policy which can be found at: http://www.senecapolytechnic.ca/about/policies/academic-integrity-policy.html Review section 2 of the policy for details regarding approaches to supporting integrity. Section 2.3 and Appendix B of the policy describe various sanctions that can be applied, if there is suspected academic misconduct (e.g., contract cheating, cheating, falsification, impersonation or plagiarism).
Please visit the Academic Integrity website http://open2.senecac.on.ca/sites/academic-integrity/for-students to understand and learn more about how to prepare and submit work so that it supports academic integrity, and to avoid academic misconduct.
Discrimination/Harassment
All students and employees have the right to study and work in an environment that is free from discrimination and/or harassment. Language or activities that defeat this objective violate the College Policy on Discrimination/Harassment and shall not be tolerated. Information and assistance are available from the Student Conduct Office at student.conduct@senecapolytechnic.ca.
Accommodation for Students with Disabilities
The College will provide reasonable accommodation to students with disabilities in order to promote academic success. If you require accommodation, contact the Counselling and Accessibility Services Office at ext. 22900 to initiate the process for documenting, assessing and implementing your individual accommodation needs.
Camera Use and Recordings - Synchronous (Live) Classes
Synchronous (live) classes may be delivered in person, in a Flexible Learning space, or online through a Seneca web conferencing platform such as MS Teams or Zoom. Flexible Learning spaces are equipped with cameras, microphones, monitors and speakers that capture and stream instructor and student interactions, providing an in-person experience for students choosing to study online.
Students joining a live class online may be required to have a working camera in order to participate, or for certain activities (e.g. group work, assessments), and high-speed broadband access (e.g. Cable, DSL) is highly recommended. In the event students encounter circumstances that impact their ability to join the platform with their camera on, they should reach out to the professor to discuss. Live classes may be recorded and made available to students to support access to course content and promote student learning and success.
By attending live classes, students are consenting to the collection and use of their personal information for the purposes of administering the class and associated coursework. To learn more about Seneca's privacy practices, visit Privacy Notice.
Prerequisite(s)
None
Topic Outline
Instructor: Oxana Iliach E-mail: oxana.iliach@senecapolytechnic.ca , Lecture room – N/A, online 4:15PM – 6:55PM
Week #/ Date |
Lecture Topic(s) | Tests / Assignments /In-class activities |
#1 Sep 9 |
Lecture 1. Introduction to Canadian Health Care System. Health Care System in USA, EU and Japan | Ice-breaker activity. Discussion and Questions & Answers of Health Care Systems in Canada, USA, EU, and Japan |
#2 Sep 16 |
Lecture 2. Introduction to Health Canada and its role in the New Drugs Approval | Discussion and Questions & Answers of federal and provincial regulations. |
#3 Sep 23 |
Lecture 3. Introduction to the Food and Drugs Act and Regulations. Division 5 of FDA | Discussion and Questions & Answers of Division 5 of FDA. |
#4 Sep 30 |
Lecture 4. Organization, Regulations on Clinical Trials in the USA | Student presentations. |
#5 Oct 7 |
Lecture 5. Introduction to ICH and Documents Relevant to Clinical Trials | In-Class Exercise: Test # 1: Health Care Systems, Division 5 FDA; 21 CFR Clinical Trial regulations in USA. Discussion and Questions & Answers of ICH guidelines. |
#6 Oct 14 |
No Class on Monday, October 14 Lecture 6. Clinical Trials Application and Investigational New Drug Application, CTA and IND for drugs and biologics |
Assignment #1 due. Discussion of CTA and IND. |
#7 Oct 21 |
Reading Week |
Review of course material |
#8 Oct 28 |
Lecture 7. Clinical Trials Inspection, Investigation, Audit – Health Canada Requirements – GMP |
Discussion and Questions & Answers of Health Canada inspection and GMP requirements |
#9 Nov 4 |
Lecture 8. Clinical Trials for NHPs |
In-Class Exercise: Test # 2: ICH, CTA, IND, Clinical Trials Inspection, Investigation, Audit. Graded Discussion. Discussion and Questions & Answers of NHPs regulations. |
#10 Nov 11 |
Lecture 9. Clinical Trials for Medical Devices |
Discussion and Questions & Answers of CTA for Medical Devices |
#11 Nov 18 |
Lecture 10. Clinical Trials Regulations in EU and Japan | Discussion and Questions & Answers of EU and Japan regulations. |
#12 Nov 25 |
Lecture 11. Health Care System and Clinical Trials Regulations in India and China |
Assignment #2 due. Discussion and Questions & Answers of CT regulations in India and China |
#13 Dec 2 |
Lecture 12. Clinical Trials Regulations in Latin America | Discussion and Questions & Answers of CT regulations in Latin America |
#14 Dec 9 |
Lecture 13. Common Technical Document, NDS and NDA. Lecture 14. Course overview and career discussion |
Discussion and Questions & Answers of NDS, NDA, supplements. In-Class Exercise: Final Test # 3: Clinical Trials for NHP and Medical Devices; CT regulations in EU, Japan, India, China, Latin America; Course overview. Discussion and Questions & Answers about future career in clinical research. |
Mode of Instruction
Online
Prescribed Texts
None
To find out the cost of books and learning material go here.
Any courses not listed on the bookstore webpage do not require any resources for purchase. All resources will be provided by your instructor.
Reference Material
- Food and Drugs Act
- Food and Drug Regulations Part C, Division 5
Required Supplies
None
Student Progression and Promotion Policy
http://www.senecapolytechnic.ca/about/policies/student-progression-and-promotion-policy.html
Grading Policyhttp://www.senecapolytechnic.ca/about/policies/grading-policy.html
A+ | 90% to 100% |
A | 80% to 89% |
B+ | 75% to 79% |
B | 70% to 74% |
C+ | 65% to 69% |
C | 60% to 64% |
D+ | 55% to 59% |
D | 50% to 54% |
F | 0% to 49% (Not a Pass) |
OR | |
EXC | Excellent |
SAT | Satisfactory |
UNSAT | Unsatisfactory |
For further information, see a copy of the Academic Policy, available online (http://www.senecapolytechnic.ca/about/policies/academics-and-student-services.html) or at Seneca's Registrar's Offices. (https://www.senecapolytechnic.ca/registrar.html).
Modes of Evaluation
Grading is based on the following marking scheme:
Assignments (2) | 26% (13% each) | ||
Presentation (1) | 5% | ||
Graded Discussion (1) | 5% | ||
Class participation | 4% | ||
In-Class Exercises: Tests (3) | 60% (20% each) | ||
|
100% |